TLR4 antagonists (Xalud Therapeutics)

N/A

Report date: 2025/01/26 16:14:48
NME

Base Information

Drug NameTLR4 antagonists (Xalud Therapeutics)
Drug Alias NameToll-like receptor 4 antagonists (Xalud Therapeutics)XT-203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 4 inhibitors
TargetsToll like receptor 4
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXalud Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesXalud Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A